• Home
  • >>>>>>>>>>>>>>>>>>> 2026 & BEYOND MASTER PLAN >>>>>>>>>>>>>>>>>>>
  • TRAINABLE DATA ASSETS IN CORPORATE LEGACY & ORGANIZATION’s STRATEGIC MEMORY (2012 – 2025)
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Founder’s Vision
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder’s Bio
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2025 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • Blockchain Transactions Network Ecosystem
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • SOP Web STAT
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series
  • Five Bilingual BioMed e-Series
  • Press Releases
  • Intangibles CIM
  • BioMed Audio Podcast Library @LPBI Group
  • Medical School Education: Use of LPBI Group’s Contents
  • ChatGPT + Wolfram PlugIn
  • Medicine with GPT-4 & ChatGPT
  • AGI, generativeAI, Grok, DeepSeek & Expert Models in Healthcare
  • Multimodal Healthcare Foundation Model
  • Cell Therapy in Regenerative Medicine, 2026 and Beyond
  • Contact Us

Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

Healthcare analytics, AI solutions for biological big data, providing an AI platform for the biotech, life sciences, medical and pharmaceutical industries, as well as for related technological approaches, i.e., curation and text analysis with machine learning and other activities related to AI applications to these industries.

Feeds:
Posts
Comments

Subsidiary 1: Leaders in Pharmaceutical Business Intelligence (LPBI) – Scientific Digital MEDIA

SUBSIDIARY #1

Scientific Digital Media @Leaders in Pharmaceutical Business Intelligence

LPBI

 

HQS – Boston, MA, Aviva Lev-Ari, PhD, RN, Editor-in-Chief

Four Lines of Business

A. Open Access online Scientific Journal 

http://pharmaceuticalintelligence.com/

B. BioMed e-Series

http://pharmaceuticalintelligence.com/biomed-e-books/

PRESS RELEASES

http://pharmaceuticalintelligence.com/2015/08/15/press-release-on-amazon-com-biomedical-e-books-e-series-by-the-team-of-leaders-in-pharmaceutical-business-intelligence-cardiovascular-genomics-cancer-biomed-patient-centered-medicine/

http://pharmaceuticalintelligence.com/2016/01/19/press-releases-from-leaders-in-pharmaceutical-business-intelligence-lpbi-five-new-e-book-in-our-biomed-e-series-are-now-available-for-kindle-on-amazon-com/

 

C. Conferences in Biotech and Medicine: REAL TIME Press Coverage 

http://pharmaceuticalintelligence.com/press-coverage/

D. FIVE Podcast – Audio Series in BioMed in the following Domains of Medicine and Life Sciences:

  • Series #1: Dr. S. Saha – Reproductive Genomics

A Podcast – Audio Series on Reproductive Genomics, Male infertility and Research Breakthroughs in Female Genomic Endocrinology

  • Series #2: Dr. SJ Williams – Genomics & Gene Therapy

A Podcast – Audio Series on Gene Editing and 3D BioPrinting

  • Series #3: Dr. SJ Williams – Genomics & Cancer

A Podcast – Audio Series on Immune-Oncology Molecules in Development

  • Series #4: Dr. A. Lev-Ari – the ART of e-Scientific Curation of Scientific Findings

A Podcast – Audio Series on CONTENT CREATION for Scientific Digital Media: Journal, e-Books, Biotech Conference Coverage in REAL TIME

  • Series #5: Dr. I. Robu – Tissue Engineering & 3D Printing Materials

A Podcast – Audio Series on Medical 3D BioPrinting

Our DOMAINS in Scientific Media

A. Open Access online Scientific Journal 

http://pharmaceuticalintelligence.com/

I.  Pharmaceutical: Biologics, Small Molecules, Diagnostics

II.  Life Sciences: Genomics and Cancer Biology

III.  Patient-centered Medicine: Focus on #1: Cardiovascular, #2: Cancer, #3: Physiology Metabolomics, Immunology

IV. Biomedicine, BioTech, and MedTech (Medical Devices)

V.  HealthCare: Patient-centered Medicine and Personalized/Precision Medicine

B. BioMed e-Series

http://pharmaceuticalintelligence.com/biomed-e-books/

BioMed e-Series

  • Series A: e-Books on Cardiovascular Diseases
  • Series B: Frontiers in Genomics Research
  • Series C: e-Books on Cancer & Oncology
  • Series D: e-Books on BioMedicine – Metabolomics, Immunology, Infectious Diseases
  • Series E: Patient-Centered Medicine — e-Books Title Plan for 2015-2016

C. Conferences in Biotech and Medicine: REAL TIME Press Coverage using Social Media and Tweet Analytics

http://pharmaceuticalintelligence.com/press-coverage/

We PROMOTE Biotech Conferences via our Journal launched on 4/2012. It will be on 12/2016 available for M&A.

  • Journal has 4,000 article, 900,000 e-Readers
  • BioMed e-Series: 15 Titles in Medicine on Amazon.com by 12/2016

We are on record as PRESS for Real Time Press Coverage of BioTech Conferences organized by: 

1  Koch Institute @MIT, 

2  Media Lab @MIT

3  Annual Personalized Medicine Conference @Harvard Medical School

4  Cambridge HealthTech Institute, World’s Largest Biotech Conference Organizer – Annual BioIT International Conference

5. MassBio

6. In 2014 (NYC), 2014 (Basel) – Sachs Associates, London

We are seeking an M&A with a European Scientific Publisher

HQS – Boston, MA

  • Scientific Journal

http://pharmaceuticalintelligence.com/

  • BioMed e-Series

http://pharmaceuticalintelligence.com/biomed-e-books/

  • Biotech and Medicine REAL TIME Press Coverage using Social Media and Tweet Analytics

http://pharmaceuticalintelligence.com/2015/08/15/press-release-on-amazon-com-biomedical-e-books-e-series-by-the-team-of-leaders-in-pharmaceutical-business-intelligence-cardiovascular-genomics-cancer-biomed-patient-centered-medicine/

Like this:

Like Loading...

This page has the following sub pages.

  • Prospective Business Partners and Valuation of Scenarios A & B & C

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 2,056 other subscribers
  • Recent Posts

    • Grok thinks like PhDs – Hybrid Model for Autonomous Update of Doctoral Dissertations with Original PhD Student Author editing and acceptance of Grok’s updated output. 3rd Joint article, a pilot study for Validation of an Autonomous Journal Articles Updating System (AJAUS) tested on Autonomous Update of Aviva Lev-Ari, PhD, RN Doctoral Thesis, UC, Berkeley, 1983. January 31, 2026
    • 2026 World Economic Forum, 1/19 – 1/23/2026, Davos, Switzerland, LPBI Group’s KOLs interpretation of AI in Health Videos January 24, 2026
    • Evolving LPBI Group’s Portfolio of Intellectual Properties (IP): From 2021 Vision to 2026 Reality January 12, 2026
    • Aviva Lev-Ari, PhD, RN – Biography ->> Grokepedia Entry January 11, 2026
    • List of Articles included in the Article SELECTION from Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com for Training Small Language Models (SLMs) in Domain-aware Content of Medical, Pharmaceutical, Life Sciences and Healthcare by 15 Subjects Matter January 10, 2026
    • Article SELECTION from Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com for Training Small Language Models (SLMs) in Domain-aware Content of Medical, Pharmaceutical, Life Sciences and Healthcare by 15 Subjects Matter January 10, 2026
    • Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com January 10, 2026
    • The youngest leader in AI in Health: Tanishq Mathew Abraham, Ph.D. (@iScienceLuvr) January 8, 2026
    • 2026 Grok Multimodal Causal Reasoning on Proprietary Cariovascular Corpus: From 2021 Wolfram NLP Baseline to Thousands of Novel Relationships – A Second Head-to-Head Validation of LPBI’s Domain-Aware Training Advantage January 6, 2026
    • Workflow for Dynamic Linkage and Transition between two Authoring Systems: LPBI Group’s WordPress.com Multi-Authors Authoring System and Microsoft PowerPoint product for Slide show presentation – Part 10.1 in Composition of Methods January 6, 2026
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 sjwilliamspa

Powered by WordPress.com.

WPThemes.


%d